BACKGROUND: The epidemiology of human papillomavirus (HPV) in Tanzania is largely unknown both in risk groups and in the general population. OBJECTIVE: To determine the cumulative seroprevalence of selected HPV types in order to evaluate exposure to HPV in urban Tanzania. METHOD: In a cross-sectional study, sera of 200 patients of both sexes with genital ulcer disease (GUD) and sera of 60 male blood donors and 60 pregnant women were tested for antibodies to the oncogenic HPV types 16, 18, 31, 33, 35, 51 and 52 using an ELISA based on virus-like particles (VLP). RESULTS: The overall seroprevalence of HPV types for all patients with GUD was 83% and 77% for women and men, respectively. For pregnant women and male blood donors, the corresponding percentages were 55% and 15%, respectively. The most common HPV types were 16, 18 and 52. Infection with multiple types was more than 10 and 5 times more frequent than infection with a single type 16 in patients with GUD and in pregnant women, respectively. The seroprevalence to HPV types 16, 18, 51 and 52 was considerably higher in HIV-positive patients with GUD than in HIV-negative patients. CONCLUSIONS: Infections with the oncogenic HPV types 16, 18 and 52 are common among patients with GUD and pregnant women in urban Tanzania, emphasising the need for control, treatment and implementation of appropriate HPV vaccine programmes.
BACKGROUND: The epidemiology of human papillomavirus (HPV) in Tanzania is largely unknown both in risk groups and in the general population. OBJECTIVE: To determine the cumulative seroprevalence of selected HPV types in order to evaluate exposure to HPV in urban Tanzania. METHOD: In a cross-sectional study, sera of 200 patients of both sexes with genital ulcer disease (GUD) and sera of 60 male blood donors and 60 pregnant women were tested for antibodies to the oncogenic HPV types 16, 18, 31, 33, 35, 51 and 52 using an ELISA based on virus-like particles (VLP). RESULTS: The overall seroprevalence of HPV types for all patients with GUD was 83% and 77% for women and men, respectively. For pregnant women and male blood donors, the corresponding percentages were 55% and 15%, respectively. The most common HPV types were 16, 18 and 52. Infection with multiple types was more than 10 and 5 times more frequent than infection with a single type 16 in patients with GUD and in pregnant women, respectively. The seroprevalence to HPV types 16, 18, 51 and 52 was considerably higher in HIV-positivepatients with GUD than in HIV-negative patients. CONCLUSIONS: Infections with the oncogenic HPV types 16, 18 and 52 are common among patients with GUD and pregnant women in urban Tanzania, emphasising the need for control, treatment and implementation of appropriate HPV vaccine programmes.
Authors: G M Clifford; S Gallus; R Herrero; N Muñoz; P J F Snijders; S Vaccarella; P T H Anh; C Ferreccio; N T Hieu; E Matos; M Molano; R Rajkumar; G Ronco; S de Sanjosé; H R Shin; S Sukvirach; J O Thomas; S Tunsakul; C J L M Meijer; S Franceschi Journal: Lancet Date: 2005 Sep 17-23 Impact factor: 79.321
Authors: Alba-Lucia Combita; Maria-Mercedes Bravo; Antoine Touzé; Oscar Orozco; Pierre Coursaget Journal: Int J Cancer Date: 2002-02-20 Impact factor: 7.396
Authors: Nubia Muñoz; F Xavier Bosch; Silvia de Sanjosé; Rolando Herrero; Xavier Castellsagué; Keerti V Shah; Peter J F Snijders; Chris J L M Meijer Journal: N Engl J Med Date: 2003-02-06 Impact factor: 91.245
Authors: Deborah L Thompson; John M Douglas; Mark Foster; Michael E Hagensee; Carolyn Diguiseppi; Anna E Barón; Jennifer E Cameron; Timothy C Spencer; Jonathan Zenilman; C Kevin Malotte; Gail Bolan; Mary L Kamb; Thomas A Peterman Journal: J Infect Dis Date: 2004-09-23 Impact factor: 5.226
Authors: Raphael P Viscidi; Linda Ahdieh-Grant; Barbara Clayman; Kelly Fox; Leslie S Massad; Susan Cu-Uvin; Keerti V Shah; Kathryn M Anastos; Kathleen E Squires; Ann Duerr; Denise J Jamieson; Robert D Burk; Robert S Klein; Howard Minkoff; Joel Palefsky; Howard Strickler; Paula Schuman; Eva Piessens; Paolo Miotti Journal: J Infect Dis Date: 2003-01-06 Impact factor: 5.226
Authors: Hugo De Vuyst; Sophia Steyaert; Lieve Van Renterghem; Patricia Claeys; Lucy Muchiri; Susan Sitati; Stijn Vansteelandt; Wim Quint; Bernard Kleter; Eric Van Marck; Marleen Temmerman Journal: Sex Transm Dis Date: 2003-02 Impact factor: 2.830
Authors: Philippe Mayaud; Helen A Weiss; Charles J N Lacey; Dilbinder K Gill; David C W Mabey Journal: J Clin Microbiol Date: 2003-09 Impact factor: 5.948
Authors: Caio Cavassan de Camargo; Karen Ingrid Tasca; Monica Banwart Mendes; Hélio Amante Miot; Lenice do Rosário de Souza Journal: Open AIDS J Date: 2014-09-30